Table 1 |.
Clinical information of cohorts involved in CRC diagnostics.
| Training cohort | Testing cohort | Total | |||
|---|---|---|---|---|---|
| Case | Non-CRC | CRC | Non-CRC | CRC | |
| 25 | 58 | 15 | 33 | 131 | |
| Age | |||||
| Median | 40 | 66 | 59 | 63 | 61 |
| Range | 18–80 | 38–80 | 25–76 | 34–82 | 18–82 |
| Sex | |||||
| Male | 14 (56%) | 35 (60%) | 10 (67%) | 19 (58%) | 78 (60%) |
| Female | 11 (44%) | 23 (40%) | 5 (33%) | 14 (42%) | 53 (40%) |
| Stage | |||||
| I | - | 9 (16%) | - | 1 (3%) | 10 (11%) |
| II | - | 22 (38%) | - | 7 (21%) | 29 (32%) |
| III | - | 16 (28%) | - | 21 (64%) | 37 (41%) |
| IV | - | 11 (18%) | - | 4 (12%) | 15 (16%) |
| Serum marker (median / range) | |||||
| CA19-9 (IU/mL) | 6.9 (0.3–24.9) |
17.8 (0.5–2167) |
4.2 (0.11–18.8) |
14.7 (0.8–188.7) |
|
| CEA (ng/mL) | 1.4 (0.4–5.2) |
3.5 (0.4–7671) |
1.5 (0.2–4.8) |
5.1 (0.4–37.8) |
|